Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
Release time:
2020-07-30
News from our newspaper 4# April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among enterprises in Jinhua Development Zone.
The selection of creative enterprises takes the effective invention patents held by enterprises as the main index. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. 2019 , Peak Pharmaceuticals applied for invention patents 2 ; obtained patent authorization 5 , of which invention 1 . By the end of 2019 , Jianfeng Pharmaceutical has obtained a total of 37 patent licenses (including PCT patent 2 ), of which 28 are inventions. There are currently valid patents 35 , of which 26 are inventions.
In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a perfect patent layout for the new drug DPT under development, applied for patent protection in many countries through the PCT application channel for core patents, and finally obtained authorization in the high-level United States and Japan, laying a good foundation for products to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5 . In addition, the pharmaceutical company has also formulated a patent acquisition plan for other varieties under research, and implemented patent applications as planned; comprehensive patent applications have been conducted and authorized for products in production (sales) to ensure scientific research results and improve product recovery Value and reputation.
In order to make intellectual property rights better create benefits for enterprises, pharmaceutical companies actively responded to the government's advocacy and made patent pledge loans for high-value patents, totaling more than 1.5 .7 billion yuan. At the same time, it is also trying to invest in patent pricing to create a new mode for the cooperation between enterprises and scientific research institutions. (Zhang Mingyin)
More information
In March, the authoritative organization of the cement industry successively released two series of lists of China's top 500 building materials enterprises in 2022 and China's top 100 cement clinker production capacity in 2022. Jianfeng Group ranked among the "top 100" in the two lists ". The list of China's top 500 building materials enterprises was officially released in early March. This series of lists was selected by the China Building Materials Enterprise Management Association. Through more than 20 years of comprehensive data research on China's building materials industry, referring to international practices, the rankings are based on the company's annual operating income., Cement products, building ceramics, waterproof materials, aluminum-plastic profiles, coatings, glass, building materials equipment manufacturing and other sub-industries related to building materials. Jianfeng Group ranks 96th among the companies on the list and 27th among the cement manufacturers on the list. On March 16, the awarding ceremony of 2022 China's top 100 cement clinker production capacity list was held in Hangzhou. This series of lists is released by China Cement Network, an authoritative organization in China's cement industry. The ranking is based on the total production capacity (excluding the production capacity of other kiln types and grinding stations) of new dry clinker production lines completed and put into operation by Chinese cement enterprises in China as of December 31, 2022. The data statistics are calculated based on the design production capacity and 310 days of annual operation. Jianfeng Group ranked 53rd with an annual design capacity of 3.627 million tons. (this newspaper reporter)
2023
03-21
Company sends off retired employees
On the morning of February 22, the trade union of the group company held a simple and warm farewell party for retired employees in 2021-2022. More than 50 retired employees gathered together to discuss and exchange with Jiang Xiaomeng and other group leaders.
2023
03-04
On the first day of the new year, group leaders went to the grassroots level.
On January 29, the first day of work after the Spring Festival holiday, the leaders of the group company made a video connection to subordinate enterprises stationed abroad, and separately visited the gold enterprises to learn about the resumption of work and put forward requirements for the implementation of the work plan for the new year.
2023
02-17
Group Companies Commend 2022 Advanced
On the morning of January 18, the group company held the 2022 annual summary commendation meeting to review the work of the previous year, make arrangements for the work in 2023, sign the 2023 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2022 advanced collectives and individuals.
2023
01-29
Jiang Xiaomeng re-elected chairman of the Municipal Federation of Industry and Commerce
On December 24, 2022, the Jinhua Federation of Industry and Commerce (General Chamber of Commerce) held the seventh member representative meeting. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, was re-elected as the chairman of the Municipal Federation of Industry and Commerce at this meeting.
2023
01-12
Peak Pharmaceutical Donates Epidemic Prevention Materials
Since the optimization and adjustment of the new crown infection epidemic management policy, there has been an explosive growth of infected people in the country, and the pressure on the supply of related materials has increased sharply. Before and after New Year's Day, the company has twice organized epidemic prevention materials, through the Jinhua City Charity Federation, Jinhua City Economic and Technological Development Zone Charity Federation targeted donations, a total value of more than 200,000 yuan.
2023
01-12